🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We’re welcoming 2025 at Arrakis, committed to pioneering a new class of genetic medicines: RNA-targeted small molecules (rSMs). We’re looking ahead to new milestones and to building relationships with new partners this year. #ExpeditionRNA arrakistx.com

Our CEO Michael Gilman, CSO Jennifer Petter and CBO James Mutamba will be in San Francisco for the JPM conference next week, Jan 13-16. Looking forward to great meetings and connections! #ExpeditionRNA #JPM2025

Today we welcome the Year of the Snake and celebrate the Lunar New Year. Those born this year are said to be intuitive, strategic and intelligent – all characteristics that describe Arrakeens! #LunarNewYear2025 #DareToBeArrakeen #YearOfTheSnake

The 2025 theme for our Diversity, Equity, Inclusion, and Belonging Program is Community. Inspired by our Arrakis peers and community, we hope to create an environment of excellence, accountability, and belonging, where everyone feels valued, respected, and safe. #DareToBeArrakeen

In February, we recognize #BlackHistoryMonth, inspired by biologist/zoologist Roger Arliner Young, the 1st African American woman to professionally publish in her field, who said “Not failure, but low aim is a crime.” We strive to be fearless and resilient, per our core values.

Today we celebrate International Day of Women & Girls in Science and recognize with gratitude the talented scientists working to create new medicines and make a difference for patients. #February11 #WomenInScience Women in Science Day #equalityinscience womeninscienceday.org

Today, Kathleen McGinness, PhD, our VP of Platform Biology, will present on our work to target RNA for new small molecule (rSM) medicines at the CHDI 20th Annual Huntington’s Disease Therapeutics Conference in Palm Springs, CA. #ExpeditionRNA #ArrakeensInAction

Arrakeens reflected on #BlackHistoryMonth, gathering to share our learnings, celebrate the historic contributions of Black Americans to our world, and to collaborate on ways to advance our community values at Arrakis.

#TBT to an article in the Journal of Medicinal Chemistry co-authored by Founder/CSO Jen & other leading female scientists sharing their inspirations and passion for inclusion within medicinal chemistry. Great read for #InternationalWomensDay. pubs.acs.org/doi/10.1021/ac…

We celebrate the amazing group of brilliant, dedicated, and accomplished women at Arrakis, as well as all of the other women in our lives, to recognize #InternationalWomensDay tomorrow. #WomenInSTEM #IWD2025

In an oral presentation at the #MDAconference 2025 next week, we will present preclinical data for our lead, rationally designed, RNA-targeted small molecule drug program for treatment of myotonic dystrophy type 1 (DM1). #ExpeditionRNA arrakistx.com/press-release/…

Today @ #MDAconference: In an oral presentation Domi Stickens, PhD, our VP of Discovery & Translational Sciences, will present preclinical data for our RNA-targeted small molecule (rSM) drug program for myotonic dystrophy type 1 (DM1), a form of muscular dystrophy. #ExpeditionRNA

Today at the 2nd Biophysics for Drug Discovery Summit in Boston, Griffin Schroeder, Scientist II, will present on our work to target RNA for new small molecule (rSM) medicines. #ExpeditionRNA #ArrakeensInAction

We honor International Transgender Day of Visibility today, in keeping with our core value of Being Human. It’s a day to celebrate the lives and contributions of trans people, while also drawing attention to the challenges the community faces. #TDOV2025 glaad.org/tdov/

At the Applied Pharmaceutical Chemistry conference in Boston today, Karthik, Director of Medicinal Chemistry, presented on our proprietary platform to develop RNA-targeted small molecule (rSMs) medicines. #ExpeditionRNA

Today, Elena, Director of Structural Biology, presents at the Drug Discovery Chemistry Conference, discussing our structure-enabled approach to developing RNA-targeted small molecule (rSMs) medicines. #ExpeditionRNA

We had a fabulous time celebrating OUTbio's 10-year anniversary celebration. We’re proud to be a corporate sponsor of this event, and proud to support their work advocating for and empowering the LGBTQ community in biotech.

May is Asian American, Native Hawaiian, and Pacific Islander Heritage Month. Throughout this month, we are celebrating the rich cultures and contributions of the AANHPI community. #AANHPI #AANHPIHeritageMonth

Arrakis is at the 2025 MDF Int'l Conference. Proud to sponsor Euro-DyMA's Pharma Day pre-event where Sarah, Director of Discovery Biology, presented. She presents at the main conference Sat on our proprietary platform for RNA-target small molecule (rSMs) medicines. #ExpeditionRNA